Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib

M Breccia; R Latagliata; F Stagno; L Luciano; A Gozzini; F Castagnetti; C Fava; F Cavazzini; M Annunziata; A Russo Rossi; P Pregno; E Abruzzese; P Vigneri; G Rege Cambrin; Simona Sica; F Pane; V Santini; G Specchia; G Rosti; G. Alimena

doi:10.3324/haematol.2011.041251

Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib

M Breccia^*, R Latagliata, F Stagno, L Luciano, A Gozzini, F Castagnetti, C Fava, F Cavazzini, M Annunziata, A Russo Rossi, P Pregno, E Abruzzese, P Vigneri, G Rege Cambrin, Simona Sica, F Pane, V Santini, G Specchia, G Rosti, G. Alimena

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

47 Citazioni (Scopus)

Abstract

Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidities have been identified as significant determinants of response to therapy in older patients with acute myeloid leukemia, breast cancer, head and neck cancer, and lung cancer. The Charlson comorbidity index and adult comorbidity evaluation-27 are lists of comorbidities with a weight assigned from 1 to 6 for the former and from 0 to 3 for the latter score, derived from relative risk estimates of a proportional hazard regression model using clinical data.

Lingua originale	Inglese
pagine (da-a)	1457-1461
Numero di pagine	5
Rivista	Haematologica
Volume	96
Numero di pubblicazione	10
DOI	https://doi.org/10.3324/haematol.2011.041251
Stato di pubblicazione	Pubblicato - 2011

All Science Journal Classification (ASJC) codes

Ematologia

Keywords

Aged
Antineoplastic Agents
BCR-ABL Positive
Chronic
Female
Humans
Incidence
Leukemia
Male
Medication Adherence
Myelogenous
Pleural Effusion
Protein Kinase Inhibitors
Pyrimidines
Retrospective Studies
Thiazoles
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.3324/haematol.2011.041251

Altri file e collegamenti

Fingerprint

Entra nei temi di ricerca di 'Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib'. Insieme formano una fingerprint unica.

Cita questo

Breccia, M., Latagliata, R., Stagno, F., Luciano, L., Gozzini, A., Castagnetti, F., Fava, C., Cavazzini, F., Annunziata, M., Russo Rossi, A., Pregno, P., Abruzzese, E., Vigneri, P., Rege Cambrin, G., Sica, S., Pane, F., Santini, V., Specchia, G., Rosti, G., & Alimena, G. (2011). Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. Haematologica, 96(10), 1457-1461. https://doi.org/10.3324/haematol.2011.041251

@article{6388bd853bb5445aa38cd688ca050dbf,

title = "Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib",

abstract = "Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidities have been identified as significant determinants of response to therapy in older patients with acute myeloid leukemia, breast cancer, head and neck cancer, and lung cancer. The Charlson comorbidity index and adult comorbidity evaluation-27 are lists of comorbidities with a weight assigned from 1 to 6 for the former and from 0 to 3 for the latter score, derived from relative risk estimates of a proportional hazard regression model using clinical data.",

keywords = "Aged, Antineoplastic Agents, BCR-ABL Positive, Chronic, Female, Humans, Incidence, Leukemia, Male, Medication Adherence, Myelogenous, Pleural Effusion, Protein Kinase Inhibitors, Pyrimidines, Retrospective Studies, Thiazoles, Treatment Outcome, Aged, Antineoplastic Agents, BCR-ABL Positive, Chronic, Female, Humans, Incidence, Leukemia, Male, Medication Adherence, Myelogenous, Pleural Effusion, Protein Kinase Inhibitors, Pyrimidines, Retrospective Studies, Thiazoles, Treatment Outcome",

author = "M Breccia and R Latagliata and F Stagno and L Luciano and A Gozzini and F Castagnetti and C Fava and F Cavazzini and M Annunziata and {Russo Rossi}, A and P Pregno and E Abruzzese and P Vigneri and {Rege Cambrin}, G and Simona Sica and F Pane and V Santini and G Specchia and G Rosti and G. Alimena",

year = "2011",

doi = "10.3324/haematol.2011.041251",

language = "English",

volume = "96",

pages = "1457--1461",

journal = "Haematologica",

issn = "1592-8721",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Breccia, M, Latagliata, R, Stagno, F, Luciano, L, Gozzini, A, Castagnetti, F, Fava, C, Cavazzini, F, Annunziata, M, Russo Rossi, A, Pregno, P, Abruzzese, E, Vigneri, P, Rege Cambrin, G, Sica, S, Pane, F, Santini, V, Specchia, G, Rosti, G & Alimena, G 2011, 'Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib', Haematologica, vol. 96, n. 10, pagg. 1457-1461. https://doi.org/10.3324/haematol.2011.041251

Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. / Breccia, M; Latagliata, R; Stagno, F et al.
In: Haematologica, Vol. 96, N. 10, 2011, pag. 1457-1461.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib

AU - Breccia, M

AU - Latagliata, R

AU - Stagno, F

AU - Luciano, L

AU - Gozzini, A

AU - Castagnetti, F

AU - Fava, C

AU - Cavazzini, F

AU - Annunziata, M

AU - Russo Rossi, A

AU - Pregno, P

AU - Abruzzese, E

AU - Vigneri, P

AU - Rege Cambrin, G

AU - Sica, Simona

AU - Pane, F

AU - Santini, V

AU - Specchia, G

AU - Rosti, G

AU - Alimena, G.

PY - 2011

Y1 - 2011

N2 - Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidities have been identified as significant determinants of response to therapy in older patients with acute myeloid leukemia, breast cancer, head and neck cancer, and lung cancer. The Charlson comorbidity index and adult comorbidity evaluation-27 are lists of comorbidities with a weight assigned from 1 to 6 for the former and from 0 to 3 for the latter score, derived from relative risk estimates of a proportional hazard regression model using clinical data.

AB - Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidities have been identified as significant determinants of response to therapy in older patients with acute myeloid leukemia, breast cancer, head and neck cancer, and lung cancer. The Charlson comorbidity index and adult comorbidity evaluation-27 are lists of comorbidities with a weight assigned from 1 to 6 for the former and from 0 to 3 for the latter score, derived from relative risk estimates of a proportional hazard regression model using clinical data.

KW - Aged

KW - Antineoplastic Agents

KW - BCR-ABL Positive

KW - Chronic

KW - Female

KW - Humans

KW - Incidence

KW - Leukemia

KW - Male

KW - Medication Adherence

KW - Myelogenous

KW - Pleural Effusion

KW - Protein Kinase Inhibitors

KW - Pyrimidines

KW - Retrospective Studies

KW - Thiazoles

KW - Treatment Outcome

KW - Aged

KW - Antineoplastic Agents

KW - BCR-ABL Positive

KW - Chronic

KW - Female

KW - Humans

KW - Incidence

KW - Leukemia

KW - Male

KW - Medication Adherence

KW - Myelogenous

KW - Pleural Effusion

KW - Protein Kinase Inhibitors

KW - Pyrimidines

KW - Retrospective Studies

KW - Thiazoles

KW - Treatment Outcome

UR - https://publicatt.unicatt.it/handle/10807/6037

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=80053634632&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80053634632&origin=inward

U2 - 10.3324/haematol.2011.041251

DO - 10.3324/haematol.2011.041251

M3 - Article

SN - 1592-8721

VL - 96

SP - 1457

EP - 1461

JO - Haematologica

JF - Haematologica

IS - 10

ER -

Breccia M, Latagliata R, Stagno F, Luciano L, Gozzini A, Castagnetti F et al. Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. Haematologica. 2011;96(10):1457-1461. doi: 10.3324/haematol.2011.041251